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Article Information  ABSTRACT 
Received: 24th March 2020  Hyaluronic acid also called as Hyaluronan, Sodium Hyaluronate (SA), sodium salt form of Hyaluronic 
acid is a biodegradable, biocompatible, and viscoelastic linear polysaccharide of a wide molecular 
weight range (1000 to 10,000,000 Da). In this project, described a method for preparing HA 
microspheres at different pH conditions by adapting a non-toxic and aqueous based crosslinking 
chemistry for sustained drug delivery of drugs. The derivatization chemistry of HA utilizing adipic 
dihydrazide has been used to construct hydrogels, applied for microsphere preparation. ADH was 
coupled efficiently to carbodimide-activated glucoronic acid residues of hyluronans. These ADH 
modified hyaluronan can be loaded with drug molecules and then cross linked into hydrogel. The drug 
was present in the bulk of hydrogel droplets which are present in liquid paraffin are precipitated by 
IPA. Formulating HA microspheres with this method have several advantages. Preliminary studies were 
conducted to confirm the better ratio of HA and ADH to show maximum entrapment efficiency and 
drug release. Then microspheres were prepared at different pH conditions and formulations were 
subjected to evaluation of various parameters like percentage yield, particle size, drug entrapment 
efficiency, porosity and bulk density, surface morphology, in vitro drug release among which F2B was 
optimized as best formulation which showed 74.6% entrapment efficiency and above 90% of drug 
release in 12 hours indicating Hyaluronic acid microspheres can be used as good carriers for sustained 
drug delivery of drugs. 
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Hyaluronic acid, microspheres, 
adipic acid, EDCI, Adipic 
dihydrazide 
INTRODUCTION 
“Microspheres can be defined as solid, approximately spherical 
particles with a diameter ranging from 1 to 1000µm, containing 
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dispersed drug in either solution (or) microcrystalline form” [1]. 
The core material, defined as the specific material to be coated, 
can be liquid or solid in nature. The coating material should be 
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capable of forming a film that is cohesive with the core 
materials, be chemically compatible and non-reactive with the 
core material and provide the desired coating properties such as 
strength, flexibility impermeability, optical properties and 
stability. Microcapsules should have desirable physical 
properties like ability to flow, to be compacted or to be 
suspended and the capsule wall must be capable of resisting the 
pressure during compression etc.  
 
Hyaluronic acid and Sodium Hyaluronate (SA) sodium salt form 
of Hyaluronic acid, is a biodegradable, biocompatible, and 
viscoelastic linear polysaccharide of a wide molecular weight 
range (1000 to 10,000,000 Da) [2]. It is composed of alternating 
disaccharide units of d-glucuronic acid and N-acetyl-d-
glucosamine with (1→4) inter glycosidic linkage and is 
distributed throughout the extracellular matrix, connective 
tissues, and organs of all higher animals [2,3] . Metabolism of 
HA occurs through the enzymatic hydrolysis by hyaluronidase 
which is present in various mammalian tissues. The HA 
molecule is readily soluble in water, producing a gel that 
behaves like a lubricant. It also absorbs water, lending it 
hygroscopic and homeostatic properties. The viscosity of the HA 
gel is dependent upon a number of factors including the length 
of the chain and by extension and the degree of entanglement, 
cross-linking, pH and chemical modification while the absolute 
concentration seems to be much less important. Cephalexin is a 
semisynthetic cephalosporin antibiotic with antimicrobial 
activity similar to that of Cephaloridine or Cephalothin, but have 
shorter biological half-life. It is effective against both gram-
positive and gram-negative organisms by binding to specific 
penicillin-binding proteins (PBPs) located inside the bacterial 
cell wall [4]. Microspheres were formulated using Hyaluronic 
acid at different pH conditions.  ADH was coupled efficiently to 
carbodiamide-activated glucoronic acid residues of hyluronans. 
These ADH modified hyaluronan loaded with drug molecules 
and then cross linked into hydrogel which has given best results 
for prompt use of hyaluronic acid microspheres for sustained 
drug delivery of drugs. 
 
MATERIAL AND METHOD 
Cephalexin is obtained as gift sample of Aurobindo labs, 
Hyaluronic acid, Adipic dihydrazide and EDCI are obtained 
from Corpuscle research solutions, Light liquid paraffin, Hcl and 
other solvents are purchased from Merck chemicals, Span 80 is 
purchased from Loba chemicals. 
Melting point determination: 
Melting point of Cephalexin was determined by “Thiele’s tube 
apparatus” to know the purity of the sample. Oil was poured into 
the Thiele’s tube, and then the handle was heated by a small 
flame. Sample in a sealed capillary, attached to a 
thermometer with a rubber band, was immersed in the tube. 
Heating was continued, and the temperature ranges at which the 
sample melted was observed and noted. 
 
Preliminary studies for selection of polymer concentration: 
Three formulations were prepared by using  different ratios of 
hyaluronan and adipic dihyrazide keeping the drug  
concentration constant  at constant pH 2.5 using 0.1N HCl 
Evaluation parameters like entrapment efficiency, Invitro drug 
release for the formulated microspheres were done and F2 was 
selected for further study. 












F1 100 1:1 1 80 
F2 100 1:2 1 80 
F3 100 1:4 1 80 
 
Preparation of microspheres 
Table 2: Formulation table 















F2A 100 3 1:2 1 80 
F2B 100 4 1:2 1 80 
F2C 100 5 1:2 1 80 
F2D 100 6 1:2 1 80 
                                                   
HA-Cefalexine microspheres were prepared by a modified 
emulsion cross linking technique [3,5]. A water-in-oil emulsion 
was formed by homogenizing 20ml of 0.5%hyaluronan solution 
with dissolved adipic di hydrazide (ADH), 80ml of mineral oil 
and 1ml span 80. This solution was mixed for 30min at 1000rpm 
using a mechanical stirrer fitted with a 0.75cm in diameter 
impeller. A solution of drug was added, the emulsion was stirred 
for an additional 20min. Afterwards, the crosslinking agent, 
Ethyl-3-[3-dimethylamino] propyl carbodimide (EDCI) 
dissolved in 2ml of distilled water and was slowly added and 
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mixed for 30min. The addition of Hydrochloric acid (HCl, 0.1N) 
was subsequently added to maintain required pH and initiated 
the crosslinking of the HA microspheres. The chemical reaction, 
at room temperature, was allowed to proceed for 24h. The HA-
cefalexine microspheres were precipitated by the addition of 
150ml of isopropyl alcohol (IPA) under vigorous agitation. 
These microspheres were centrifuged at 1500rpm for 5min. The 
supernatant was discarded and the microspheres were washed 
three times by centrifugation with IPA (1500rpm for 5min) 
 
After the final wash, the microspheres were resuspended in a 
reagent mixture containing ADH and EDCI (1:1) dissolved in 
100ml of 90% IPA. This mixture was gently stirred using a stir 
bar and magnetic plate. HCl (0.1N) was subsequently added to 
maintain required pH to initiate the second crosslinking reaction. 
After 24h, the microspheres were collected by centrifugation and 
washed three times with 90%IPA to remove the traces of mineral 
oil which may affect the drug release from microspheres. They 
were subjected for drying.   
 
Evaluation of formulated microspheres [4-15]: 
Percentage yield [4-8]: 
It was calculated using the weight of spheres recovered from 
each batch in relation to the sum of starting material. Percentage 






Bulk density and porosity [4]: 
The bulk density and porosity of the prepared microspheres were 
determined according the standard procedures mentioned in I.P. 
 
Particle size determination [7,8]:   
Microspheres size was measured by optical microscopy. The 
mean diameter was determined by measuring the number of 
divisions covered by microspheres using ocular micrometer 
previously calibrated using stage micrometer. 
 
Drug entrapment efficiency [7,8]: 
5mg spheres of each batch were placed in 10ml phosphate buffer 
pH 7.4 and mechanically agitated on shaker at 200rpm for 24hrs. 
The resultant solution was filtered and analyzed at 261nm using 
UV visible spectrophotometer. The percentage drug entrapment 
efficiency (%EE) of microspheres was calculated by using the 
following equation 
%𝐸𝐸𝐸𝐸 = 𝐴𝐴𝐴𝐴 𝑇𝑇𝐴𝐴� × 100 
where, AQ is actual drug content and TQ is theoretical drug 
content. 
  
Surface Morphology [7-15]: 
In order to obtain information on the shape and surface structure 
of the material, SEM analysis was performed. 
 
In Vitro drug release [7-15]: 
 The dissolution studies of the microspheres equivalent to 
100mg of cephalexin were performed using USP dissolution 
apparatus II. The drug release study was carried out in pH 7.4 
phosphate buffer up to 12hrs, maintained at 37±2oC and agitated 
at 100rpm. Samples were collected periodically and replaced 
with fresh dissolution media. After filtration through muslin 
cloth, concentration of cephalexin was determined 
spectrophotometrically at 261nm. 
 
RESULTS AND DISCUSSION 
Melting point determination: 
The melting point of obtained drug sample was found to be 
196oC which is within the reported range 196- 198oC. It 
complies with the purity of the drug sample. 
 
Standard calibration curve of cephalexin: 
The absorbance of standard solutions of cephalexin ranging from 
2-10µg/ml in pH 7.4 phosphate buffer was observed and the 
standard calibration curve for Cephalexin was constructed.                                                          
 
Figure 1: Calibration curve of Cephalexin 
Preliminary studies for selection of ratio of HA And ADH 
ratio for preparation of microspheres:  
Based upon the results of preliminary studies, the F2 formulation 
was selected for further studies as it showed higher entrapment 
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efficiency of 64.56% and highest In vitro drug release of 
54.883% within 10hrs. 
Table 3: %EE and %DR of F1, F2, &F3 
Formulation % EE % DR in 10hrs. 
F1 52.78 50.45 
F2 64.56 54.883 
F3 55.34 49.22 
 
Percentage yield: 
Percentage yield of all formulations was calculated and found to 
be ranging from 27.47 to 73.86%.  
Bulk density and Porosity: 
Bulk densities of microspheres ranges from 1.73±0.05 to 
0.72±0.07g/cc. The bulk density of F2C and F2D microspheres 
were less as compared with microspheres and F2B. The decrease 
in bulk density was observed with increase in size and porosity. 
Table 4: Evaluation results of microspheres 
Formulation 
code 
HA and ADH 
ratio 
% yield Bulk density 
(g/cc) 
Porosity Particle size 
(µm) 
%EE 
F2A 1:2 44.2 1.73±0.05 14.55 9.46±0.058 64.5623 
F2B 1:2 73.86 1.42±0.17 18.35 9.86±0.069 74.6576 
F2C 1:2 36.29 0.91±0.27 28.34 10.04±0.068 47.3760 
F2D 1:2 27.47 0.78±0.13 32.12 10.65±0.064 20.556 
Particle size determination: 
The drug loaded microspheres were spherical in shape. The size 
of microspheres were in the range of 9.46 to 10.65µm. The 
particle size increased with the increase of pH. This can be 
attributed to the distention of drug loaded HA gel spheres due to 
entrapped gas bubbles. The increased pH may be responsible for 
softening of spheres leading to deformation under force of 
agitation. 
 
Drug entrapment efficiency: 
Entrapment efficiency was more at pH 4. Batch F2D prepared at 
pH 6 showed lowest drug entrapment than other batches having 
acidified crosslinking solution. It may be due to decreased 
crosslinking efficiency at higher pH. 
 
Surface Morphology: 
The water-in-oil emulsion of HA, Cefalexin and mineral oil that 
was cross linked with adipic dihydrazide produced microspheres 
with spherical conformation and heterogeneous size distribution. 
The median and mean diameters HA- Cefalexin microspheres 
were 6 and 10µm respectively, as indicated by particle size 
analyser. 
 
Drug release studies: 
The dissolution study of all formulations of cefalexin was 
carried out in phosphate buffer pH 7.4. Almost 50% drug 
released in 6hrs and with in12hrs 90% drug released in all 
formulations prepared at different pH conditions. Among all pH 
conditions selected for microspheres preparation, pH 4 used for 
f2B formulation shown highest drug release. 
 
Figure 2: SEM of HA-Cefalexin microspheres of F2B 
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Drug release kinetics: 
 
Figure 4: Zero order plot for all formulations 
 
Figure 5: First order plot for all formulations 
 












R2 n value 
F2A 0.9815 0.9738 0.9709 0.9847 0.8042 
F2B 0.9755 0.9951 0.9833 0.9839 0.7842 
F2C 0.9655 0.9918 0.968 0.9657 0.8814 
F2D 0.9698 0.9818 0.9669 0.9535 0.7999 
Table No.6: 'n' value in Korsmeyer Peppas plot 
Release exponent (n) Drug transport mechanism 
<0.45 Fickian transport 
0.45-0.89 Non fickian transport 
>0.89 Case II trans port 
      
 
Figure 6: Higuchi plot for all formulations 
 
 
Figure 7: Korsmeyer Peppas plot for all formulations 
y = 6.6233x + 4.0246
R² = 0.9815
y = 6.3057x + 5.6254
R² = 0.9755
y = 6.4429x + 2.6714
R² = 0.9665























F2A F2B F3C F4D
y = -0.0539x + 2.0194
R² = 0.9738
y = -0.0494x + 2.0046
R² = 0.9951
y = -0.0482x + 2.0158





















F2A F2B F3C F4D
y = 26.233x - 16.056
R² = 0.9709
y = 25.21x - 13.918
R² = 0.9833
y = 25.677x - 17.149
R² = 0.968
y = 26.953x - 16.743
R² = 0.9669










F2A F2B F3C F4D
y = 0.8042x + 1.0217
R² = 0.9847
y = 0.7824x + 1.0448
R² = 0.9839
y = 0.8814x + 0.9276
R² = 0.9657
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Based on the r2 values of the zero order and first order drug 
release plots and as the 'n' value in of the all formulations is in 
between 0.45 -0.89, it can be concluded that the optimized 
formulation is showing first order drug release and following 
non fickian transport of release mechanism i.e., diffusion with 
swelling and relaxation of polymer [16].  
 
CONCLUSION 
An attempt was made to prepare HA microspheres by adapting 
a non-toxic and aqueous based cross linking chemistry for 
sustained drug delivery of drugs. The selected drug Cephalexin 
was successfully loaded in HA microspheres and the 
encapsulation efficiency was found to be nearly 75% depending 
on the ratio of HA and ADH for microspheres. It was also 
observed that change in pH condition during preparation 
effected %EE but not the % drug release due to proper washings. 
Observing the all evaluation tests results, among all pH 
conditions selected for microspheres preparation, pH 4 used for 
f2B formulation was found to be acceptable.   
 
All formulations prepared were showing sustained release of 
drug according to USP up to 12hrs. From the optimized 
formulation the drug release was following first order and non 
fickian transport of release mechanism as the 'n' value in the 
korsmeyer peppas model is 0.7842. So it can be concluded that 
nontoxic and aqueous based crosslinking method can be 
adaptable for Hyaluronic acid microspheres preparation and 
these microspheres can be used as perfect vehicle for sustained 
delivery of drugs. 
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